In an innovative twist on Trinidad’s holiday traditions, home-based entrepreneurs are transforming classic Christmas beverages into cannabis-infused medicinal products, creating an unexpected but lucrative market. While cannabis remains largely illegal for sale and public consumption in Trinidad and Tobago, artisans are leveraging social media to build demand for therapeutic-infused versions of ponche de creme and sorrel—traditional holiday drinks typically enjoyed during the festive season.
The movement gained momentum during the pandemic when hospitality workers facing unemployment sought alternative income sources. Tron, founder of Rum and Resin, launched his operation with a team of retrenched workers, while Blue established Bloom Delights—both operating anonymously due to legal constraints. Their businesses have evolved from side hustles into full-time ventures, responding to growing consumer demand for diverse cannabis delivery methods beyond conventional edibles.
These entrepreneurs emphasize the medicinal rather than recreational applications of their products. Their offerings include cannabis-infused teas for sleep and immunity support, as well as formulations using marijuana roots to address asthma and gout. Customer bases consist primarily of professionals and parents seeking relief from anxiety, depression, and stress-related conditions. One notable case involves a woman using cannabis products to supplement treatment for hormonal thyroid issues when conventional medications proved unavailable locally.
Global shifts in cannabis perception are influencing local attitudes. The recent reclassification of marijuana under the U.S. Controlled Substances Act from Schedule I to Schedule III—recognizing its medical applications—has created ripple effects in Trinidad’s underground market. This scientific validation coincides with findings from the FDA supporting cannabis use for treating anorexia and chronic pain.
Despite growing acceptance, legal barriers persist. The Dangerous Drugs (Amendment) Act of 2019 decriminalized possession of up to 30 grams of cannabis but maintained prohibitions on sales and public consumption. This legal limbo forces artisans to operate in a gray market, limiting production scales and creating quality control challenges. Some unscrupulous vendors reportedly use imported marijuana or synthetic additives that compromise therapeutic properties and consumer safety.
Political change may be imminent. The United National Congress party has pledged to develop a regulated cannabis industry for medical and export purposes if elected, projecting a global market worth over $100 billion by 2030. Their proposal includes support for small farmers, quality control systems, and age restrictions prohibiting use under 25.
For now, entrepreneurs like Tron and Blue navigate significant legal risks while advocating for reform. As Blue notes, ‘Most people in this industry understand the medicinal benefits—it’s about making money while giving back to society. What we need is a proper framework to prevent abuse.’ Their success demonstrates both the economic potential and therapeutic value of a properly regulated cannabis industry in Trinidad and Tobago.